Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kathleen D. Scott currently holds 10,042 shares of Dermata Therapeutics, Inc. (DRMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen D. Scott has been a net seller of DRMA stock. They have purchased $51.5K and sold $387.5K worth of shares.
Kathleen D. Scott's most recent insider trade was on Aug 21, 2025, when they sold 12,500 shares at $15.00 per share.
Kathleen D. Scott serves as Executive at Dermata Therapeutics, Inc. (DRMA). They have executed 15 insider transactions totaling $439.0K over their tenure at the company.
Kathleen D. Scott holds the position of Executive at Dermata Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Kathleen D. Scott has shown a selling trading pattern, with $51.5K in total purchases and $387.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kathleen D. Scott was on Aug 20, 2024, when they sold $200.0K worth of SPRY shares. This transaction involved 12,500 shares at $16.00 per share.
Kathleen D. Scott currently owns 10,042 shares of Dermata Therapeutics, Inc. (DRMA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kathleen D. Scott's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kathleen D. Scott has 15 Form 4 filings on record as an insider at Dermata Therapeutics, Inc..
Set alerts for Kathleen D. Scott and 40,000+ other insiders.